Email updates

Keep up to date with the latest news and content from Breast Cancer Research and BioMed Central.

Editorial

Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are needed

Laura Stanbery1* and Elizabeth M Petty2

Author Affiliations

1 University of Michigan Medical School, Department of Internal Medicine-Hematology/Oncology, 7111 Comprehensive Cancer Center, Ann Arbor, MI 48109, USA

2 University of Wisconsin School of Medicine and Public Health, 4121 Health Sciences Learning Center, 750 Highland Ave, Madison, WI 53705, USA

For all author emails, please log on.

Breast Cancer Research 2012, 14:101  doi:10.1186/bcr3056


See related research by Connolly et al., http://breast-cancer-research.com/content/13/4/R76

Published: 9 January 2012

Abstract

Septins comprise a conserved family of GTPase proteins. Of these, human SEPT9 has been widely implicated in cancers of epithelial origin, including breast cancer, as well as leukemia. In a previous issue of Breast Cancer Research, Connolly and colleagues present compelling data further supporting a role for SEPT9 isoforms in early breast cancer development as well as evidence suggesting that cellular localization patterns of SEPT9 isoforms may contribute to oncogenesis.